يعرض 1 - 13 نتائج من 13 نتيجة بحث عن '"prevention & control [Alzheimer Disease]"', وقت الاستعلام: 0.48s تنقيح النتائج
  1. 1
  2. 2
  3. 3

    المصدر: Nature reviews / Neurology 17(11), 703-714 (2021). doi:10.1038/s41582-021-00545-1

    وصف الملف: Print-Electronic

  4. 4

    المساهمون: Amsterdam Neuroscience - Neurodegeneration, Epidemiology and Data Science, APH - Methodology, Neurology, APH - Personalized Medicine, CCA - Imaging and biomarkers, CCA - Cancer biology and immunology, Radiology and nuclear medicine, Amsterdam Neuroscience - Brain Imaging, Amsterdam Neuroscience - Cellular & Molecular Mechanisms, Amsterdam Neuroscience - Neuroinfection & -inflammation, Epidemiology and biostatistics

    المصدر: Alzheimer's and Dementia, 16(10), 1457-1468. Elsevier
    Alzheimers & Dementia, 16(10), 1457-1468. Elsevier
    Alzheimer's & Dementia, Vol. 16, No 10 (2020) pp. 1457-1468
    Frisoni, G B, Molinuevo, J L, Altomare, D, Carrera, E, Berkhof, J, Delrieu, J, Dubois, B, Kivipelto, M, Nordberg, A, Schott, J M, van der Flier, W M, Vellas, B, Jessen, F, Scheltens, P & Ritchie, C 2020, ' Precision prevention of Alzheimer's and other dementias: Anticipating future needs in the control of risk factors and implementation of disease-modifying therapies ', Alzheimer's and Dementia, vol. 16, no. 10, pp. 1457-1468 . https://doi.org/10.1002/alz.12132
    Alzheimer's and dementia 16(10), 1457-1468 (2020). doi:10.1002/alz.12132
    NARCIS

  5. 5

    المصدر: Nutrients
    Nutrients, Vol 10, Iss 7, p 852 (2018)
    Nutrients 10(7), 852 (2018). doi:10.3390/nu10070852
    Volume 10
    Issue 7

    وصف الملف: application/pdf

  6. 6

    المؤلفون: Robert Perneczky

    المساهمون: Perneczky, R

    المصدر: New York, NY : Springer New York, Methods in Molecular Biology 1750, 15-29 (2018). doi:10.1007/978-1-4939-7704-8_2
    Biomarkers for Alzheimer’s Disease Drug Development / Perneczky, Robert (Editor) ; New York, NY : Springer New York, 2018, Chapter 2 ; ISSN: 1064-3745=1940-6029 ; ISBN: 978-1-4939-7703-1=978-1-4939-7704-8 ; doi:10.1007/978-1-4939-7704-8
    Biomarkers for Alzheimer’s Disease Drug Development ISBN: 9781493977031

  7. 7

    المصدر: Neurobiology of Aging
    Cox, C J, Choudhry, F, Peacey, E, Perkinton, M S, Richardson, J C, Howlett, D R, Lichtenthaler, S F, Francis, P T & Williams, R J 2015, ' Dietary (-)-epicatechin as a potent inhibitor of βγ-secretase amyloid precursor protein processing ', Neurobiology of Aging, vol. 36, no. 1, pp. 178-187 . https://doi.org/10.1016/j.neurobiolaging.2014.07.032
    Neurobiology of aging 36(1), 178-187 (2015). doi:10.1016/j.neurobiolaging.2014.07.032

    وصف الملف: application/pdf

  8. 8

    المصدر: The American journal of psychiatry 175(3), 232-241 (2018). doi:10.1176/appi.ajp.2017.17040404

  9. 9

    المساهمون: Neurology

    المصدر: Journal of internal medicine, 275(3), 229-250. Wiley-Blackwell
    Journal of Internal Medicine, 275, 229-50
    Journal of Internal Medicine, 275, 3, pp. 229-50
    Journal of internal medicine 275(3), 229-250 (2014). doi:10.1111/joim.12178

  10. 10

    المصدر: The journal of clinical psychiatry 73(12), e1492-e1498 (2012). doi:10.4088/JCP.11m07270

  11. 11
  12. 12

    المساهمون: Neurology, Amsterdam Neuroscience - Neurodegeneration, Epidemiology and Data Science

    المصدر: The lancet 388(10043), 505-517 (2016). doi:10.1016/S0140-6736(15)01124-1
    Lancet, 388(10043), 505-517. Elsevier Limited
    The Lancet, Vol. 388, No 10043 (2016) pp. 505-517
    Scheltens, P, Blennow, K, Breteler, M M B, de Strooper, B, Frisoni, G B, Salloway, S & Van der Flier, W M 2016, ' Alzheimer's disease ', Lancet, vol. 388, no. 10043, pp. 505-517 . https://doi.org/10.1016/S0140-6736(15)01124-1

  13. 13

    المصدر: The Lancet. Neurology, vol 14, iss 4
    ResearcherID
    The lancet / Neurology 14(4), 388-405 (2015). doi:10.1016/S1474-4422(15)70016-5
    Lancet Neurology, 14, 388-405
    Heneka, MT; Carson, MJ; Khoury, JE; Landreth, GE; Brosseron, F; Feinstein, DL; et al.(2015). Neuroinflammation in Alzheimer's disease. The Lancet Neurology, 14(4), 388-405. doi: 10.1016/S1474-4422(15)70016-5. UCLA: Retrieved from: http://www.escholarship.org/uc/item/99h2f9m1
    Lancet Neurology, 14, 4, pp. 388-405
    Heneka, M T, Carson, M J, Khoury, J E, Landreth, G E, Brosseron, F, Feinstein, D L, Jacobs, A H, Wyss-Coray, T, Vitorica, J, Ransohoff, R M, Herrup, K, Frautschy, S A, Finsen, B, Brown, G C, Verkhratsky, A, Yamanaka, K, Koistinaho, J, Latz, E, Halle, A, Petzold, G C, Town, T, Morgan, D, Shinohara, M L, Perry, V H, Holmes, C, Bazan, N G, Brooks, D J, Hunot, S, Joseph, B, Deigendesch, N, Garaschuk, O, Boddeke, E, Dinarello, C A, Breitner, J C, Cole, G M, Golenbock, D T & Kummer, M P 2015, ' Neuroinflammation in Alzheimer's disease ', Lancet Neurology, vol. 14, no. 4, pp. 388-405 . https://doi.org/10.1016/S1474-4422(15)70016-5
    The Lancet Neurology

    مصطلحات موضوعية: Aging, MILD COGNITIVE IMPAIRMENT, lnfectious Diseases and Global Health Radboud Institute for Molecular Life Sciences [Radboudumc 4], Disease, Alzheimer's Disease, Systemic inflammation, Severity of Illness Index, Inflammation/diagnosis, immunology [Inflammation], Aetiology, metabolism [Inflammation], blood [Biomarkers], Microglia, complications [Obesity], pathology [Microglia], RANDOMIZED CONTROLLED-TRIAL, immunology [Microglia], Disease Progression, Locus Coeruleus, Anti-Inflammatory Agents, Non-Steroidal/therapeutic use, Central nervous system, Clinical Sciences, CEREBRAL AMYLOID ANGIOPATHY, Article, administration & dosage [Nootropic Agents], Phagocytosis, Alzheimer Disease, Humans, Inflammation Mediators/immunology, NITRIC-OXIDE SYNTHASE, GENOME-WIDE ASSOCIATION, Locus Coeruleus/pathology, pathology [Locus Coeruleus], Animal, Prevention, Inflammatory and immune system, CENTRAL-NERVOUS-SYSTEM, Immunity, Immunity, Innate, diagnosis [Inflammation], immunology [Alzheimer Disease], nervous system, Astrocytes, Brain Injuries, Immunology, Dementia, Neurology (clinical), Obesity/complications, Neuroscience, Biomarkers, Protein Folding, Microglia/immunology, Anti-Inflammatory Agents, genetics [Alzheimer Disease], Neurodegenerative, prevention & control [Alzheimer Disease], pathology [Alzheimer Disease], Risk Factors, Brain Injuries/complications, complications [Brain Injuries], 2.1 Biological and endogenous factors, Innate, Nootropic Agents, therapeutic use [Anti-Inflammatory Agents, Non-Steroidal], pathology [Astrocytes], Clinical Trials as Topic, Nootropic Agents/administration & dosage, Anti-Inflammatory Agents, Non-Steroidal, Pattern recognition receptor, medicine.anatomical_structure, cerebrospinal fluid [Biomarkers], Neurological, medicine.symptom, Inflammation Mediators, immunology [Inflammation Mediators], Non-Steroidal, metabolism [Alzheimer Disease], Astrocytes/immunology, ANTIINFLAMMATORY PREVENTION TRIAL, TRAUMATIC BRAIN-INJURY, immunology [Astrocytes], metabolism [Brain Injuries], POSITRON-EMISSION-TOMOGRAPHY, metabolism [Obesity], Acquired Cognitive Impairment, medicine, Animals, ddc:610, Obesity, TRANSGENIC MOUSE MODEL, Neuroinflammation, Inflammation, Alzheimer Disease/genetics, Innate immune system, Neurology & Neurosurgery, business.industry, metabolism [Inflammation Mediators], Neurosciences, Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD), Brain Disorders, Disease Models, Animal, Disease Models, Immunization, business, Biomarkers/blood

    وصف الملف: application/pdf